BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33674164)

  • 1. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates.
    Runner RP; Shau DN; Staley CA; Roberson JR
    J Arthroplasty; 2021 Jul; 36(7):2364-2370. PubMed ID: 33674164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
    Bala A; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Clin Orthop Relat Res; 2017 Sep; 475(9):2205-2213. PubMed ID: 28569372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
    Sidhu VS; Naylor JM; Adie S; Lieu D; Walker R; Horsley M; Kim RG; Harris IA
    Clin Orthop Relat Res; 2023 Jul; 481(7):1351-1359. PubMed ID: 36649465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous Thromboembolism in Total Hip and Total Knee Arthroplasty.
    Simon SJ; Patell R; Zwicker JI; Kazi DS; Hollenbeck BL
    JAMA Netw Open; 2023 Dec; 6(12):e2345883. PubMed ID: 38039005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020.
    Santana DC; Emara AK; Orr MN; Klika AK; Higuera CA; Krebs VE; Molloy RM; Piuzzi NS
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32824931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin prophylaxis is not associated with increased risk of venous thromboembolism in arthroplasty for femoral neck fractures: a non-inferiority study.
    Habibi AA; Brash A; Rozell JC; Ganta A; Schwarzkopf R; Arshi A
    Eur J Orthop Surg Traumatol; 2024 Apr; 34(3):1405-1411. PubMed ID: 38197969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin or enoxaparin for VTE prophylaxis after primary partial, total or revision hip or knee arthroplasty: A secondary analysis from the CRISTAL cluster randomized trial.
    CRISTAL Study Group
    PLoS One; 2024; 19(4):e0298152. PubMed ID: 38626226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with Australian Orthopaedic Association guidelines does not reduce the risk of venous thromboembolism after total hip and knee arthroplasty.
    Badge H; Churches T; Naylor JM; Xuan W; Armstrong E; Gray L; Fletcher J; Gosbell I; Lin CC; Harris IA
    Sci Rep; 2024 Mar; 14(1):5955. PubMed ID: 38467650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey.
    Rogers BA; Phillips S; Foote J; Drabu KJ
    Ann R Coll Surg Engl; 2010 Nov; 92(8):668-72. PubMed ID: 20615303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of postoperative single-dose anticoagulant treatment in preventing venous thromboembolism after revision hip arthroplasty: a retrospective cohort study.
    Chu C; Mu W; Wahafu T; Zou C; Xu B; Cao L
    Int Orthop; 2023 Nov; 47(11):2709-2716. PubMed ID: 37491609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
    Kapoor A; Chuang W; Radhakrishnan N; Smith KJ; Berlowitz D; Segal JB; Katz JN; Losina E
    Pharmacoeconomics; 2010; 28(7):521-38. PubMed ID: 20550220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism prophylaxis in shoulder surgery: a break-even cost-effectiveness study.
    Martinazzi BJ; Stauch CM; Monahan PF; King JL; Walley KC; Kirchner GJ; Updegrove GF
    J Shoulder Elbow Surg; 2024 Jun; 33(6):1228-1234. PubMed ID: 37944745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Adjusted Modified Frailty Index Predicts 30-Day Complications and Mortality in Aseptic Revision Total Hip and Knee Arthroplasty.
    Zamanzadeh RS; Seilern Und Aspang JRM; Schwartz AM; Martin JR; Premkumar A; Wilson JM
    J Arthroplasty; 2024 Jan; 39(1):198-205. PubMed ID: 37380143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis.
    Migliorini F; Maffulli N; Velaj E; Bell A; Kämmer D; Hildebrand F; Hofmann UK; Eschweiler J
    J Orthop Traumatol; 2024 Jan; 25(1):1. PubMed ID: 38194191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thromboembolism after total hip and knee replacement in older adults with comorbidity and co-occurring comorbidities in the Nationwide Inpatient Sample (2003-2006).
    Kapoor A; Labonte AJ; Winter MR; Segal JB; Silliman RA; Katz JN; Losina E; Berlowitz D
    BMC Geriatr; 2010 Sep; 10():63. PubMed ID: 20846450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty.
    Gutiérrez-Guisado J; Calvo-Sotelo AE; Hernández-Blasco L; Fidalgo Á; Gómez-Cuervo C; López-Ruiz A; Aibar J; Verhamme P; Meireles J; Monreal M
    Thromb Res; 2024 May; 237():94-99. PubMed ID: 38574519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in deep vein thrombosis prophylaxis after total hip arthroplasty: 2016 to 2021.
    Moore MC; Dubin JA; Bains SS; Hameed D; Nace J; Delanois RE
    J Orthop; 2024 Feb; 48():77-83. PubMed ID: 38059214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Deep Vein Thrombosis Prophylaxis After Total Knee Arthroplasty: 2016 to 2021.
    Dubin JA; Bains SS; Hameed D; Remily EA; Moore MC; Mont MA; Nace J; Delanois RE
    J Arthroplasty; 2024 Feb; ():. PubMed ID: 38325530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons Learned: Using the Caprini Risk Assessment Model to Provide Safe and Efficacious Thromboprophylaxis Following Hip and Knee Arthroplasty.
    Krauss ES; Cronin M; Dengler N; Simonson BG; Enker P; Segal A
    Clin Appl Thromb Hemost; 2020; 26():1076029620961450. PubMed ID: 33141613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence rates and risk factors of in-hospital venous thromboembolism, major bleeding, and death in patients receiving fondaparinux after orthopedic surgery or trauma surgery.
    Ding Y; Han B; Yuan B; Nie M; Liu R; Zhao M; Wang H
    Ir J Med Sci; 2023 Dec; 192(6):2973-2979. PubMed ID: 36787027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.